Filter Results:
(549)
Show Results For
- All HBS Web
(549)
- People (1)
- News (221)
- Research (225)
- Events (1)
- Multimedia (11)
- Faculty Publications (138)
Show Results For
- All HBS Web
(549)
- People (1)
- News (221)
- Research (225)
- Events (1)
- Multimedia (11)
- Faculty Publications (138)
- November 12, 2018
- Article
Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology
By: Richard G. Hamermesh and Kathy Giusti
Hamermesh, Richard G., and Kathy Giusti. "Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology." Fortune.com (November 12, 2018).
- 01 Mar 2012
- News
Sun Dress
Barrow: Offering a line of clothing that provides protection from the downside of solar energy. A native of sun-splashed Australia who now resides in Minneapolis, John Barrow (MBA 1989) has a fashion tip for Americans: cover up, mates. Seriously. Skin-cancer awareness... View Details
- June 2012
- Teaching Note
Cancer Treatment Centers of America: Scaling the Mother Standard of Care (TN)
By: Rosabeth Moss Kanter and Matthew Bird
- November 2018
- Case
David Hysong and SHEPHERD Therapeutics
By: Ananth Raman, John Masko and Aldo Sesia
In 2016, David Hysong, at age 27, found out he had a rare, incurable cancer. Rather than wait around to die, Hysong, a recent graduate of Harvard Divinity School, decided to launch a biotechnology company called Shepherd Therapeutics to development treatments for his... View Details
- January 2012 (Revised October 2012)
- Supplement
Ganging Up on Cancer: Integrative Research Centers at the Dana-Farber Cancer Institute (B)
By: Heidi K. Gardner, Edo Bedzra and Shereef M. Elnahal
Gardner, Heidi K., Edo Bedzra, and Shereef M. Elnahal. "Ganging Up on Cancer: Integrative Research Centers at the Dana-Farber Cancer Institute (B)." Harvard Business School Supplement 412-098, January 2012. (Revised October 2012.)
- Article
Lack of Shared Decision Making in Cancer Screening Discussions: Results from a National Survey
By: Richard M. Hoffman, Joanne G. Elmore, Kathleen M. Fairfield, Bethany S. Gerstein, Carrie A. Levin and Michael P. Pignone
Hoffman, Richard M., Joanne G. Elmore, Kathleen M. Fairfield, Bethany S. Gerstein, Carrie A. Levin, and Michael P. Pignone. "Lack of Shared Decision Making in Cancer Screening Discussions: Results from a National Survey." American Journal of Preventive Medicine 47, no. 3 (September 2014): 251–259.
- September 2017 (Revised February 2023)
- Case
Intermountain Healthcare: Pursuing Precision Medicine
By: Richard G. Hamermesh, Kathy E. Giusti, Robert S. Huckman and Julia Kelley
Headquartered in Salt Lake City, Intermountain Healthcare operates 23 hospitals and hundreds of clinics in Utah and Idaho and provides insurance to approximately 850,000 patients through its insurance arm, SelectHealth. In 2013, Intermountain, known for its commitment... View Details
Keywords: Precision Medicine; Healthcare; Innovation; Cancer; Cancer Research; Health Care; Technology; Health Care and Treatment; Innovation Leadership; Disruptive Innovation; Entrepreneurship; Decision Choices and Conditions; Health Industry; Insurance Industry; Utah; United States; North America
Hamermesh, Richard G., Kathy E. Giusti, Robert S. Huckman, and Julia Kelley. "Intermountain Healthcare: Pursuing Precision Medicine." Harvard Business School Case 818-018, September 2017. (Revised February 2023.)
- Article
Patterns of Technology Use Among Patients with Head and Neck Cancer and Implications for Telehealth
By: Chloe Warinner, Tuna Cem Hayirli, Regan Bergmark, Rosh Sethi and Eleni Rettig
Warinner, Chloe, Tuna Cem Hayirli, Regan Bergmark, Rosh Sethi, and Eleni Rettig. "Patterns of Technology Use Among Patients with Head and Neck Cancer and Implications for Telehealth." OTO Open 5, no. 2 (April–June 2021).
- November 2020 (Revised May 2021)
- Technical Note
Tales of Life-changing Innovations: Reducing Breast Cancer Risks | Note on the Development of Tamoxifen (through 1999)
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Tales of Life-changing Innovations: Reducing Breast Cancer Risks | Note on the Development of Tamoxifen (through 1999)." Harvard Business School Technical Note 321-058, November 2020. (Revised May 2021.)
- March 2012 (Revised March 2012)
- Teaching Note
Ganging up on Cancer: Integrative Research Centers at the Dana-Farber Cancer Institute (TN) (A) and (B)
By: Heidi K. Gardner
Keywords: Health Industry
- October 2023
- Article
Health System Perspective on Cost for Delivering a Decision Aid for Prostate Cancer Using Time-Driven Activity-Based Costing
By: David R. Ho, Robert S. Kaplan, Jonathan Bergman, David F. Penson, Benjamin Waterman, Kristin C. Williams, Jefersson Villatoro, Lorna Kwan and Christopher S. Saigal
Previsit decision aids (DAs) have been shown to improve decisional quality. But the cost to deploy a DA has not been previously estimated. We interviewed or observed relevant personnel at three institutions that had implemented DA programs for men with prostate cancer.... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Cost Accounting; Health Industry
Ho, David R., Robert S. Kaplan, Jonathan Bergman, David F. Penson, Benjamin Waterman, Kristin C. Williams, Jefersson Villatoro, Lorna Kwan, and Christopher S. Saigal. "Health System Perspective on Cost for Delivering a Decision Aid for Prostate Cancer Using Time-Driven Activity-Based Costing." Medical Care 61, no. 10 (October 2023): 681–688.
- 16 Jul 2019
- News
The Making of a Movement
making decisions that could advance treatment options for patients with rare cancers. Neither of the Linns worked in science or medicine. A few years earlier, rare cancers had not even been on their radar. Now it was possible their... View Details
- September 2017 (Revised July 2023)
- Case
Adaptive Platform Trials: The Clinical Trial of the Future?
By: Ariel D. Stern and Sarah Mehta
In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
- May 2014
- Case
Cycle for Survival (A)
By: Das Narayandas, Kerry Herman and Noah Fisher
Katie Kotkins, director of Memorial Sloan Kettering Cancer Center's (MSKCC) Cycle for Survival fundraising event, had to determine the best avenue for continuing the event's success and momentum after its founder, Jennifer (Jen) Goodman Linn (HBS '99) passed away... View Details
Keywords: Not For Profit; Cancer; Partnerships; United States; Fundraising; Nonprofit Organizations; United States
Narayandas, Das, Kerry Herman, and Noah Fisher. "Cycle for Survival (A)." Harvard Business School Case 514-076, May 2014.
- June 2020
- Case
Breakthroughs at Blueprint Medicines
By: Richard G. Hamermesh, Kathy Giusti and Susie L. Ma
Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development... View Details
Keywords: Precision Medicine; Cancer; Biotechnology; Drug Development; Strategy; Expansion; Science; Genetics; Information Technology; Entrepreneurship; Organizational Culture; Management; Growth and Development; Pharmaceutical Industry; United States; Cambridge; Massachusetts
Hamermesh, Richard G., Kathy Giusti, and Susie L. Ma. "Breakthroughs at Blueprint Medicines." Harvard Business School Case 820-001, June 2020.